Asia-Pacific Health Industries 2015: Keeping You Up-To-Date With The Latest Developments

By PricewaterhouseCoopers Special Report: Healthcare in Asia South East Asia New Health Era in South East Asia There is no other sector as important as health. Health matters to each of us as individuals. It is our most precious and valuable asset and connects us all like no other. Health also matters to society. It lies … Read more

Mergers & Acquisitions Quarterly Switzerland – Second Quarter 2015

By Ronald Sauser and Thomas Korzec – Ernst & Young In the second quarter of 2015, Swiss M&A activity continued to decline. As the wave of mega deals grinded to a halt and economic indicators worsened, as the Swiss Franc gained strength, both the number and volume of transactions suffered, dipping well below its long-term historic average. Looking ahead … Read more

Direct And Indirect International Experience Of Shareholders, Ownership Structure And Cross-Border M&A

Figure 1 Direct experience and indirect experience

by Elsevier Ltd.
Prior research suggests that international experience only are directly learnt by firms’ international operations. In this study, we argue that majority shareholders are part and parcel of the network of internal and external international experience. Based on the sample of 307 cross-border M&A of 741 majority shareholders in 188 Chinese listing enterprises for the 2005–2014 time period, we measure direct international experience and indirect international experience using centrality analysis in two-model social network. […] Read more

Direct And Indirect International Experience Of Shareholders, Ownership Structure And Cross-Border M&A

By Chenxi Guo, Ping Lv Abstract Prior research suggests that international experience only are directly learnt by firms’ international operations. In this study, we argue that majority shareholders are part and parcel of the network of internal and external international experience. Based on the sample of 307 cross-border M&A of 741 majority shareholders in 188 Chinese listing enterprises … Read more

Approach To The Issues Of Leadership In The Processes Of Companies’ Acquisitions

Table 2 Approach to the issues of leadership in the process of acquisition in the examined pharmaceutical companies

by Elsevier Ltd.
This paper presents the results of the research concerning five transactions in the pharmaceutical sector. The research aim was to diagnose an approach to the issues of leadership, which in the literature is often treated as a key success factor in the processes of acquisitions. The research showed that in the analyzed pharmaceutical companies which participated in the research little attention was paid to the issues of leadership. […] Read more

Managing Mergers: A Conversation With Rob Leary

By Onur Erzan and Bryce Klempner – McKinsey & Company The president of TIAA-CREF Asset Management talks about why the industry is likely to see more tie-ups, how to prepare for big deals, and why finding growth depends on what you’re good at. Rob Leary joined the Teachers Insurance and Annuity Association of America–College Retirement Equities Fund (TIAA-CREF) in June 2013. Less … Read more

Global Transactions Forecast: The Impact Of Macro Trends On Future M&A And IPO Activity

Figure 1 Global MA-IPO transactions

by Baker & McKenzie
The fundamental drivers of global transactions are pointing to a continued strong upturn in M&A and IPOs over the next three years. Global economic growth is expected to accelerate, and low interest rates and easy credit conditions in key countries are likely to maintain upward momentum in equity markets. […] Read more

Global Transactions Forecast: The Impact Of Macro Trends On Future M&A And IPO Activity

By Baker & McKenzie EXECUTIVE SUMMARY The fundamental drivers of global transactions are pointing to a continued strong upturn in M&A and IPOs over the next three years. Global economic growth is expected to accelerate, and low interest rates and easy credit conditions in key countries are likely to maintain upward momentum in equity markets.  Many … Read more

Die größten Pharmaunternehmen der Welt

Eine Analyse wichtiger Finanzkennzahlen für die Geschäftsjahre 2012, 2013 und 2014 By Erich Lehner – Ernst & Young Design der Analyse ► Quellen: Geschäftsberichte, Pressemitteilungen der Unternehmen, SEC-Filings. ► Analysiert wurden die Pharma-Umsätze der 20 weltweit umsatzstärksten börsennotierten Pharma-Unternehmen. Branchenfremde Aktivitäten sind nicht in die Analyse eingeflossen. ► Die Angaben beziehen sich auf die Geschäftsjahre 2012, 2013 und 2014. ► Als „Top 10“ … Read more

Are you sure you
want to log out?

In order to become a charterholder you need to complete one of the IMAA programs